Search Results 301-310 of 11739 for Drug-resistant TB
The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...
The U.S. Food and Drug Administration has ... image Mayo Clinic researchers identify molecule linked to treatment-resistant inflammatory bowel disease.
By condition, treatment or drug name ... They are currently being treated for latent TB or the site has documentation of successful prior treatment of latent TB.
About this study. Study consists of two main parts to explore tacabrutideg recommended dosing, a Phase 1 monotherapy dose finding comprised of monotherapy ...
... drug-resistant. Featured News. New study in Brain Communications finds personalized deep brain stimulation shows promise for drug-resistant epilepsy. Alison ...
... Resistant To Current Standard Of Care Treatments. Rochester, Minn. This study is researching an experimental drug called linvoseltamab in combination with ...
Drug Interactions. Although certain medicines ... You will need to have a skin test for tuberculosis (TB) before you or your child start receiving this medicine.
The goal of this clinical study is to determine the safety and efficacy of VT-464, a lyase-selective inhibitor of CYP17 and an androgen receptor antagonist, in ...
Zika virus and antibiotic-resistant bacteria are among the top infectious disease concerns of health officials, says Dr. Gregory Poland, director of Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.